Return of Research-Related Genetic Test Results and Genetic Discrimination Concerns: Facilitators and Barriers of Genetic Research Participation in Diverse Groups.


Journal

Public health genomics
ISSN: 1662-8063
Titre abrégé: Public Health Genomics
Pays: Switzerland
ID NLM: 101474167

Informations de publication

Date de publication:
2020
Historique:
received: 12 02 2019
accepted: 08 03 2020
pubmed: 15 4 2020
medline: 22 12 2020
entrez: 15 4 2020
Statut: ppublish

Résumé

Most genetics studies lack the diversity necessary to ensure that all groups benefit from genetic research. To explore facilitators and barriers to genetic research participation. We conducted a survey on genetics in research and healthcare from November 15, 2017 to February 28, 2018 among adult Kaiser Permanente (KP) members who had been invited to participate in the KP biobank (KP Research Bank). We used logistic regression to calculate adjusted odds ratios (ORs) and 95% confidence intervals (CIs) comparing the willingness to participate in genetic research under different return of results scenarios and genetic discrimination concerns between groups, according to their demographic characteristics. A total of 57,331 KP members were invited to participate, and 10,369 completed the survey (18% response rate). Respondents were 65% female, 44% non-Hispanic White (NH White), 22% Asian/Native Hawaiian or other Pacific Islander (Asian/PI), 19% non-Hispanic Black (NH Black), and 16% Hispanic. Respondents willing to participate in genetic research ranged from 22% with no results returned to 87% if health-related genetic results were returned. We also found variation by race/ethnicity; when no results were to be returned, Asian/PIs, Hispanics, and NH Blacks were less likely to want to participate than NH Whites (p < 0.05). However, when results were returned, disparities in the willingness to participate disappeared for NH Blacks and Hispanics. Genetic discrimination concerns were more prevalent in Asian/PIs, Hispanics, and NH Blacks than in NH Whites (p < 0.05). Policies that prohibit the return of results and do not address genetic discrimination concerns may contribute to a greater underrepresentation of diverse groups in genetic research.

Sections du résumé

BACKGROUND
Most genetics studies lack the diversity necessary to ensure that all groups benefit from genetic research.
OBJECTIVES
To explore facilitators and barriers to genetic research participation.
METHODS
We conducted a survey on genetics in research and healthcare from November 15, 2017 to February 28, 2018 among adult Kaiser Permanente (KP) members who had been invited to participate in the KP biobank (KP Research Bank). We used logistic regression to calculate adjusted odds ratios (ORs) and 95% confidence intervals (CIs) comparing the willingness to participate in genetic research under different return of results scenarios and genetic discrimination concerns between groups, according to their demographic characteristics.
RESULTS
A total of 57,331 KP members were invited to participate, and 10,369 completed the survey (18% response rate). Respondents were 65% female, 44% non-Hispanic White (NH White), 22% Asian/Native Hawaiian or other Pacific Islander (Asian/PI), 19% non-Hispanic Black (NH Black), and 16% Hispanic. Respondents willing to participate in genetic research ranged from 22% with no results returned to 87% if health-related genetic results were returned. We also found variation by race/ethnicity; when no results were to be returned, Asian/PIs, Hispanics, and NH Blacks were less likely to want to participate than NH Whites (p < 0.05). However, when results were returned, disparities in the willingness to participate disappeared for NH Blacks and Hispanics. Genetic discrimination concerns were more prevalent in Asian/PIs, Hispanics, and NH Blacks than in NH Whites (p < 0.05).
CONCLUSIONS
Policies that prohibit the return of results and do not address genetic discrimination concerns may contribute to a greater underrepresentation of diverse groups in genetic research.

Identifiants

pubmed: 32289795
pii: 000507056
doi: 10.1159/000507056
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

59-68

Informations de copyright

© 2020 S. Karger AG, Basel.

Auteurs

Andrea N Burnett-Hartman (AN)

Institute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado, USA, Andrea.N.Burnett-Hartman@kp.org.

Erica Blum-Barnett (E)

Institute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado, USA.

Nikki M Carroll (NM)

Institute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado, USA.

Sarah D Madrid (SD)

Institute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado, USA.

Cabell Jonas (C)

Mid-Atlantic Permanente Research Institute, Kaiser Permanente Mid-Atlantic States, Rockville, Maryland, USA.

Kristen Janes (K)

Kaiser Permanente Care Management Institute, Oakland, California, USA.

Monica Alvarado (M)

Southern California Permanente Medical Group, Pasadena, California, USA.

Ruth Bedoy (R)

Institute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado, USA.

Valerie Paolino (V)

Institute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado, USA.

Nazneen Aziz (N)

Variant Genomics, Inc., Oakland, California, USA.

Elizabeth A McGlynn (EA)

Kaiser Permanente Research, Pasadena, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH